Oral gemifloxacin versus IV cefotaxime for peritonitis
Part of Digestive system, Infections clinical trials.
This trial compares two antibiotic treatments for spontaneous bacterial peritonitis—one taken by mouth (gemifloxacin) versus one given through a vein (cefotaxime). It may help find the best way to treat this infection and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have spontaneous bacterial peritonitis (an infection of the belly fluid that happens on its own).
- Your peritonitis is not from a known cause like an injury or surgery (it must be primary/spontaneous).
- Your doctor must confirm the type of peritonitis before you can join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking norfloxacin plus itopride helps prevent another episode of spontaneous bacterial peritonitis (a serious belly infection) in people with cirrhosis and fluid buildup in the abdomen. It compares that combo to norfloxacin alone to see which approach better lowers repeat infections.
This trial compares starting antibiotics through a vein (IV) to taking them by mouth for common infections like pneumonia, urinary tract infections, or skin infections (cellulitis). The goal is to see if oral antibiotics work just as well without the need for an IV line.
This trial compares two antibiotic treatments for liver abscess: one given through an IV (into a vein) and one taken as pills by mouth. The goal is to see if the oral treatment works just as well, which could make treatment easier and more convenient for patients.
This trial tests whether a newer antibiotic (ceftolozane/tazobactam) works as well as the standard drug (meropenem) for treating fever and low white blood cell counts in people who carry or are at risk for a certain type of resistant bacteria (ESBL). If you are colonized with ESBL or have recently used certain antibiotics, you may be eligible.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
This study compares two strong antibiotics to see which one works better for people with liver failure who get a hospital-acquired infection caused by resistant bacteria. The two drugs are ceftazidime-avibactam and a higher dose of meropenem given as an extended infusion.
Hear when a new Spontaneous Bacterial Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.